PROCTER & GAMBLE Co

The Procter & Gamble Company announced that its Board of Directors declared a quarterly dividend of $1.0885 per share. This dividend applies to both Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock. It is payable on or after August 17, 2026, to shareholders of record as of July 24, 2026. The company highlighted its long-standing commitment to shareholders, having paid dividends for 136 consecutive years and increased them for 70 consecutive years.

The Procter & Gamble Company (PG) filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026. This report provides a comprehensive overview of the company's financial performance and condition for the third fiscal quarter of 2026. It includes consolidated financial statements and management's discussion and analysis of financial condition and results of operations.

The Procter & Gamble Company announced its third quarter results on April 24, 2026. The company issued a press release and hosted a conference call to discuss these results. Informational slides referenced during the conference call have been furnished on Form 8-K and are also available on the company's website.

Procter & Gamble announced strong third-quarter fiscal year 2026 results, with net sales increasing 7% to $21.2 billion and organic sales growing 3%. Diluted EPS rose 6% to $1.63, while core EPS increased 3% to $1.59. The company also reaffirmed its fiscal year guidance for sales, EPS growth, and cash returns, indicating confidence in its ongoing performance.

The Procter & Gamble Company announced that its Board of Directors declared a quarterly dividend of $1.0885 per share on its Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock. This dividend is scheduled for payment on or after May 15, 2026. Shareholders of record for Common Stock will be determined at the close of business on April 24, 2026, while Preferred Stock shareholders of record will be determined at the start of business on the same date.

Procter & Gamble filed an 8-K announcing its first quarter results and hosted a conference call to discuss them. The company furnished informational slides related to the results on Form 8-K and posted them on its website. This provides investors with insights into the company's performance and future outlook.

Procter & Gamble released its earnings for the quarter ended September 30, 2025. The company furnished the information in an 8-K filing, indicating the release contains important information regarding the company's financial performance and results of operations.

Procter & Gamble closed underwritten public offerings of €500 million of 2.900% Notes due 2033 and €500 million of 3.650% Notes due 2045. Additionally, P&G closed offerings of $750 million of 4.100% Notes due 2032 and $500 million of 4.350% Notes due 2035, increasing the company's debt.

Procter & Gamble (PG) announced the closing of an underwritten public offering of $258.889 million aggregate principal amount of Floating Rate Notes due November 4, 2075. This debt offering provides P&G with additional capital and reflects its ongoing capital management strategy.

Jennifer Davis, Chief Executive Officer of Procter & Gamble's Health Care division, has announced her intention to retire effective June 30, 2026, after more than 33 years with the company. This represents a significant leadership change within a key business segment for P&G.